Kirin Holdings Company, Limited Sponsored Adr News, Kirin Holdings Company, Limited Sponsored Adr Quote, KNBWY Quote

Kirin Holdings Company, Limited Sponsored Adr (OP:KNBWY) Delayed: 17.51 +0.13 (0.75%)

Prev. Close

$17.38

Today 6M 1Y 5Y

Open

$17.53

52 Wk High

$18.64

52 Wk Low

$12.59

Day High

$17.57

Day Low

$17.46

P/E

N/A

EPS

$0.00

Volume

5,807

Friends, Peers and Foes (?): KYKOY, 2503:JP, KAOOY, ARDX, BBIO (more...)

ALERTS | RSS

Jun 11, 2026 08:03 AM Kura Oncology reports positive long-term cancer drug trial data
Jun 11, 2026 08:02 AM Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
May 14, 2026 08:30 AM FDA approves dosing update for CRYSVITA in adults with rare bone disease
May 14, 2026 08:30 AM FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH
May 12, 2026 09:40 AM Kura Oncology and Kyowa Kirin to Present Updated Frontline Ziftomenib / 7+3 Combination Data at EHA 2026 Congress
May 6, 2026 08:01 AM CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program
Apr 24, 2026 08:00 AM Kyowa Kirin begins phase 2 trial of ziftomenib in Japan for AML
Apr 24, 2026 08:00 AM Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML
Apr 23, 2026 02:47 AM UBS Downgrades Kirin Holdings Co Ltd (2503:JP) (KNBWY) to Neutral
Apr 10, 2026 03:49 AM Kirin Holdings Co Ltd (2503:JP) (KNBWY) PT Raised to JPY2,500 at Nomura/Instinet

Entities mentioned with KNBWY

View All Entities